Benchmarks
Nifty24,121.3542.85
FEATURED FUNDS★★★★★
Motilal Oswal Midcap Fund Direct-Growth
5Y Return
23.43 %
Invest Now
Enter search text:
The Economic Times daily newspaper is available online now.
Read Today’s Paper
Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley’s acquisition: Report
Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley’s acquisition: Report
By ReutersLast Updated: Jul 16, 2026, 10:31:00 AM IST
Synopsis
Eli Lilly is reportedly negotiating to acquire psychedelic drugmaker AtaiBeckley. AtaiBeckley shares experienced a significant surge following the news of these discussions. The company focuses on mental health treatments using psychedelic-based compounds. AtaiBeckley is developing an intranasal formulation for treatment-resistant depression. Talks are ongoing, and a deal could be announced this week
Reuters
Eli Lilly is in talks to acquire psychedelic drugmaker AtaiBeckley and a deal could be announced as soon as this week, Bloomberg News reported on Wednesday, citing people familiar with the matter.AtaiBeckley shares soared 66% in aftermarket trading, while Lilly was flat. AtaiBeckley was up 31% so far this year and had a market value of $1.97 billion as of Wednesday’s close, according to LSEG data.Lilly is negotiating a deal at a premium, Bloomberg News said.Eli Lilly and AtaiBeckley were not immediately available for comment outside regular business hours. New York-based AtaiBeckley focuses on psychedelic-based treatments for mental health conditions and is developing BPL-003, an intranasal formulation of 5-MeO-DMT for treatment-resistant depression.The company’s shares received a boost this year after U.S. President Donald Trump ordered health regulators to speed up reviews of psychedelic treatments and increased federal funding for their research.Add 
as a Reliable and Trusted News Source
Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News on
Eli Lilly acquisitionAtaiBeckleypsychedelic drugmakermental health treatmentspsychedelic treatments researchdrug market news
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News on
Eli Lilly acquisitionAtaiBeckleypsychedelic drugmakermental health treatmentspsychedelic treatments researchdrug market news
Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories & personalised newsletters
Login Now
Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions & in-depth stock reports
Subscribe Now
ET
Unlock Access to All Exclusives with ETPrime FREE TRIAL
15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers
Trial offer expiring in00 : 05 : 00
I’d rather pay ₹2599 now
Uh-oh! This is an exclusive story available for selected readers only
Worry not. You’re just a step away
Prime Account Detected!
It seems like you’re already an ETPrime member with
Login using your ET Prime credentials to enjoy all member benefits
Log out of your current logged-in accountand log in again using your ET Prime credentials to enjoy all member benefits
Unlock ETPrime’s Exclusive Stories Today!
Big Price Drop! Flat 40% Off
Student Only Offer
Already a Member? Sign In now
Already a Member? Sign In now
Already a Member? Sign In now
Offer Exclusively For You
Save up to Rs. 700/-
ON ET PRIME MEMBERSHIP
Avail Offer
Offer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail Offer
Offer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail Offer
Offer Exclusively For You
Get Flat 40% Off
Then ₹ 1749 for 1 year
Avail Offer
Offer Exclusively For You
ET Prime at ₹ 49 for 1 month
Then ₹ 1749 for 1 year
Avail Offer
Special Offer
Get flat 40% off on ETPrime
Avail Offer
Avail Offer
Claim NowAlready a Member? Sign In now
‘;
});
}
if(listing) {
var h3 = “You tried reading ” + listArr.length + ” locked stories in the past ” + threshold + ” days.”, h4 = “Become an ET Prime member and don’t miss out on these exclusive stories.”;
var html =
‘
‘ + h3 + ‘
‘ + h4 + ‘
- ‘ + listing + ‘
‘;
$(‘#paidSCWidget’).html(html);
var callback = $(‘#paidSCWidget’).attr(‘data-callback’);
if(callback && window[callback]) {
window[callback]();
}
customDimension.dimension72 += ‘ | Shown SYFT no Trial_With Missed Paywalled Articles Collection’;
} else {
_processNormal()
}
}
});
} else {
_processNormal();
}
} catch (e) {
_processNormal();
}
}, function () {
_processNormal();
});
//console.log(‘storyCollectionLoad’, $);
}
What’s Included with
ETPrime Membership
1Exclusive Insights That Matter
Uncover the truth with our investigative stories
Make strategic moves using the real-world case studies
Read industry-specific stories to identify emerging trends
Spot opportunities with in-depth insights that matter
Trump temper on H-1B visas is forcing Indians to do these things to stay put in US
What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer
Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?
The problem with lab grown diamonds
Why a falling rupee is a better option for the economy
A list of top 20 momentum stocks that have delivered massive returns in one year
2Invest Wisely With Smart Market Tools & Investment Ideas
Alpha Trade
Get daily trade ideas from SEBI-registered research analysts
Investment Ideas
Grow your wealth with stock ideas & sectoral trends
Stock Reports Plus
All-in-one stock research with Stock Score, peer comparison & key signals
BigBull Portfolio
Get to know where the market bulls are investing to identify the right stocks
Stock Analyzer
Check the score based on the company’s fundamentals, solvency, growth, risk & ownership to decide the right stocks
Market Mood
Analyze the market sentiments & identify the trend reversal for strategic decisions
Stock Talk Live at 9 AM Daily
Ask your stock queries & get assured replies by ET appointed, SEBI registered experts
3Stay informed anytime, anywhere with ET ePaper
ePaper – Print View
Read the PDF version of ET newspaper. Download & access it offline anytime
ePaper – Digital View
Read your daily newspaper in Digital View & get it delivered to your inbox everyday
Wealth Edition
Manage your money efficiently with this weekly money management guide
4Times Of India Subscription (1 Year)
TOI ePaper
Read the PDF version of TOI newspaper. Download & access it offline anytime
Deep Explainers
Explore the In-depth explanation of complex topics for everyday life decisions
Health+ Stories
Get fitter with daily health insights committed to your well-being
Personal Finance+ Stories
Manage your wealth better with in-depth insights & updates on finance
New York Times Exclusives
Stay globally informed with exclusive story from New York Times
5Enjoy Complimentary Subscriptions From Top Brands
Docubay Subscription
Stream new documentaries from all across the world every day
Stories you might be interested in
